Abstract
Chemotherapy-induced respiratory failure is being increasingly recognized as a cause of respiratory failure in the intensive care unit. The frequency of chemotherapy-induced respiratory failure is low, however with increasing number of patients receiving new chemotherapeutic agents more cases can be expected to be seen. Chemotherapy-induced respiratory failure can be due to bronchospasm and hypersensitivity reactions, pulmonary hemorrhage, interstitial pneumonitis, eosinophilic pneumonia, and non-cardiogenic pulmonary edema. Pulmonary and critical care physicians should be aware of the clinical presentation of chemotherapy-induced respiratory failure.
Keywords: Pulmonary toxicity, pneumonitis, respiratory failure, chemotherapy
Current Respiratory Medicine Reviews
Title: Respiratory Failure in Cancer Patients: Non-Infectious Complications of Antineoplastic Agents for Solid Tumors
Volume: 3 Issue: 3
Author(s): Bobbak Vahid and Paul E. Marik
Affiliation:
Keywords: Pulmonary toxicity, pneumonitis, respiratory failure, chemotherapy
Abstract: Chemotherapy-induced respiratory failure is being increasingly recognized as a cause of respiratory failure in the intensive care unit. The frequency of chemotherapy-induced respiratory failure is low, however with increasing number of patients receiving new chemotherapeutic agents more cases can be expected to be seen. Chemotherapy-induced respiratory failure can be due to bronchospasm and hypersensitivity reactions, pulmonary hemorrhage, interstitial pneumonitis, eosinophilic pneumonia, and non-cardiogenic pulmonary edema. Pulmonary and critical care physicians should be aware of the clinical presentation of chemotherapy-induced respiratory failure.
Export Options
About this article
Cite this article as:
Bobbak Vahid and Paul E. Marik , Respiratory Failure in Cancer Patients: Non-Infectious Complications of Antineoplastic Agents for Solid Tumors, Current Respiratory Medicine Reviews 2007; 3 (3) . https://dx.doi.org/10.2174/157339807781387544
DOI https://dx.doi.org/10.2174/157339807781387544 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art
Current Radiopharmaceuticals Recent Advances in Perioperative Anesthetic Management Update in the Perioperative Support of Patients with Septic Shock and the Effect on Outcomes
Current Pharmaceutical Design Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders
Central Nervous System Agents in Medicinal Chemistry Pediatric Heart Failure in the Developing World
Reviews on Recent Clinical Trials New Targets of Therapy in T-Cell Lymphomas
Current Drug Targets Malaria Stage-Specific Vaccine Candidates
Current Pharmaceutical Design Osteoporotic Fracture Healing: Potential Use of Medicinal Plants from the Tropics
Current Drug Targets Targeted Therapies in Head and Neck Cancer: Past, Present and Future
Reviews on Recent Clinical Trials Different Concepts of Drug Delivery in Disease Entities
Mini-Reviews in Medicinal Chemistry Thrombolysis in Ischemic Stroke: Focus on New Treatment Strategies
Recent Patents on Cardiovascular Drug Discovery Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
Current Neuropharmacology TRYCAT Pathways Link Peripheral Inflammation, Nicotine, Somatization and Depression in the Etiology and Course of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Combination of Phytosterols and Omega-3 Fatty Acids: A Potential Strategy to Promote Cardiovascular Health
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Hurdles in the Drug Discovery of Cathepsin K Inhibitors
Current Topics in Medicinal Chemistry Role of Heme Oxygenase-1 in Vascular Disease
Current Pharmaceutical Design Stroke Subtypes and their Possible Implication in Stroke Prevention Drug Strategies
Current Vascular Pharmacology Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Current Medicinal Chemistry Prevention and Repair of Circulatory Shock and Cerebral Ischemia/Injury by Various Agents in Experimental Heatstroke
Current Medicinal Chemistry The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection
Current Rheumatology Reviews Contrast Agents in X-Ray Computed Tomography and Its Applications in Oncology
Anti-Cancer Agents in Medicinal Chemistry